A case series of serious and unexpected adverse drug reactions under treatment with cariprazine

被引:3
|
作者
Heck, Johannes [1 ]
Seifert, Johanna [2 ]
Stichtenoth, Dirk O. [1 ,3 ]
Schroeder, Christoph [1 ,4 ]
Groh, Adrian [2 ]
Szycik, Gregor R. [2 ]
Degner, Detlef [5 ]
Adamovic, Ivana [5 ]
Schneider, Michael [6 ]
Glocker, Catherine [7 ]
Ruther, Eckart [7 ,8 ]
Bleich, Stefan [2 ]
Grohmann, Renate [7 ]
Toto, Sermin [2 ]
机构
[1] Hannover Med Sch, Inst Clin Pharmacol, Carl Neuberg Str 1, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Hannover, Germany
[3] Hannover Med Sch, Hannover, Germany
[4] Hannover Med Sch, Pharmacovigilance, Hannover, Germany
[5] Georg August Univ Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany
[6] Univ Clin Psychiat & Psychotherapy, Brandenburg Med Sch, Immanuel Klin, Rudersdorf, Germany
[7] Ludwig Maximilian Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany
[8] Prosomno Klin & Poliklin Schlafmed, Munich, Germany
来源
CLINICAL CASE REPORTS | 2021年 / 9卷 / 05期
关键词
adverse drug reactions; cariprazine; dopamine supersensitivity psychosis; drug safety; hyperprolactinemia;
D O I
10.1002/ccr3.4084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring ("black triangle" label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Adverse Cutaneous Drug Reactions - Case Series
    Sukanya, M.
    Srinivasan, Shreya
    Sanjay, Nehete Sanket
    Kumar, Ashok N.
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (05): : 32 - 35
  • [2] Under-reporting of serious adverse drug reactions in Sweden
    Bäckström, M
    Mjörndal, T
    Dahlqvist, R
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (07) : 483 - 487
  • [3] Serious adverse drug reactions in elderly
    Charfi, R.
    El Adli, S.
    Zaeem, A.
    Kastalli, S.
    Sraeri, S.
    Daghfous, R.
    Lakhal, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 79 - 79
  • [4] Evaluating Serious Adverse Drug Reactions
    Somberg, John
    Molnar, Janos
    CARDIOLOGY, 2018, 139 (03) : 202 - 202
  • [5] Reports of Serious Adverse Drug Reactions
    Gruszycki, M. R.
    Alba, D. A.
    Gruszycki, A. E.
    Tauguinas, A. L.
    Osicka, R. M.
    DRUG SAFETY, 2008, 31 (10) : 899 - 899
  • [6] Reports of Serious Adverse Drug Reactions
    M. R. Gruszycki
    D. A. Alba
    A. E. Gruszycki
    A. L. Tauguinas
    R. M. Osicka
    Drug Safety, 2008, 31 : 885 - 885
  • [7] Parkinsonism caused by adverse drug reactions: A case series
    Ugoya S.O.
    Agaba E.I.
    Daniyam C.A.
    Journal of Medical Case Reports, 5 (1)
  • [8] Evaluation of the extent of under-reporting of serious adverse drug reactions - The case of toxic epidermal necrolysis
    Mittmann, N
    Knowles, SR
    Gomez, M
    Fish, JS
    Cartotto, R
    Shear, NH
    DRUG SAFETY, 2004, 27 (07) : 477 - 487
  • [9] Antibiotics associated serious adverse drug reactions
    Haase, G
    Müller, C
    Drewelow, B
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 688 - 689
  • [10] Prevention Model for Serious Adverse Drug Reactions
    Thiankhanithikun, K.
    Kaewvichit, S.
    DRUG SAFETY, 2009, 32 (10) : 913 - 914